Insider Transactions in Q4 2017 at Spero Therapeutics, Inc. (SPRO)
Insider Transaction List (Q4 2017)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 06
2017
|
Glaxosmithkline PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
428,571
+18.78%
|
$5,999,994
$14.0 P/Share
|
Nov 06
2017
|
Glaxosmithkline PLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,425,435
+35.48%
|
-
|